NM_001025295.3(IFITM5):c.-14C>T AND Postmenopausal osteoporosis
- Germline classification:
- Pathogenic (1 submission)
- Last evaluated:
- Jun 14, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001526510.3
Allele description [Variation Report for NM_001025295.3(IFITM5):c.-14C>T]
NM_001025295.3(IFITM5):c.-14C>T
Condition(s)
- Name:
- Postmenopausal osteoporosis
- Synonyms:
- BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS; OSTEOPOROSIS, INVOLUTIONAL
- Identifiers:
- MONDO: MONDO:0008159; MedGen: C0029458
-
INSIG2 insulin induced gene 2 [Homo sapiens]
INSIG2 insulin induced gene 2 [Homo sapiens]Gene ID:51141Gene
-
(INSIG2[Gene Name]) AND Homo sapiens[Organism] AND (alive[prop]) (1)
Gene
-
BNIP3 BCL2 interacting protein 3 [Homo sapiens]
BNIP3 BCL2 interacting protein 3 [Homo sapiens]Gene ID:664Gene
-
(BNIP3[Gene Name]) AND Homo sapiens[Organism] AND (alive[prop]) (1)
Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 13, 2024